Hillsdale Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

Hillsdale Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-137,900	Closed	-$3.06M	–	657
2021 Q2	$3.06M	Hold	137,900	–	–	0.24%	137
2021 Q1	$3.62M	Sell	137,900 -46,700	-25%	-$1.11M	0.3%	118
2020 Q4	$3.45M	Sell	184,600 -700	-0.4%	-$13.1K	0.33%	104
2020 Q3	$3.15M	Buy	185,300 +200	+0.1%	+$3.89K	0.31%	97
2020 Q2	$4.31M	Buy	+185,100	New	+$2.68M	0.39%	57
2016 Q2	–	Sell	-32,700	Closed	-$674K	–	574
2016 Q1	$674K	Hold	32,700	–	–	0.23%	59
2015 Q4	$671K	Buy	32,700 +4,800	+17%	+$92K	0.26%	51
2015 Q3	$477K	Sell	27,900 -2,900	-9%	-$53K	0.16%	104
2015 Q2	$574K	Sell	30,800 -2,200	-7%	-$40.8K	0.17%	106
2015 Q1	$630K	Buy	33,000 +16,200	+96%	+$300K	0.16%	112
2014 Q4	$277K	Buy	+16,800	New	+$288K	0.07%	266

Other funds holding VIVO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Hillsdale Investment Management's VIVO Position: Q3 2021 in Review

Hillsdale Investment Management sold out of Meridian Bioscience Inc (VIVO) in Q3 2021, closing a stake of 137,900 shares — an estimated $3.06M sold.

Hillsdale Investment Management first reported a position in VIVO in Q4 2014 and held it in 11 quarters. The position peaked at $4.31M in Q2 2020. 180 funds tracked by Wall St. Rank hold VIVO as of Q3 2021.

Hillsdale Investment Management reported no remaining Meridian Bioscience Inc position as of Q3 2021 after selling out during the quarter.
Hillsdale Investment Management sold 137,900 Meridian Bioscience Inc shares in Q3 2021, an estimated $3.06M.
Hillsdale Investment Management first reported a position in Meridian Bioscience Inc in Q4 2014 and held it in 11 quarters.
Hillsdale Investment Management's Meridian Bioscience Inc position peaked at $4.31M in Q2 2020.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q3 2021.

Based on Hillsdale Investment Management's 13F filing for Q3 2021, filed 21 Oct 2021.